Bilateral External Torque CT, a Novel Diagnostic Tool for Detection of Syndesmotic Insufficiency
1 other identifier
observational
20
1 country
1
Brief Summary
Study population: the investigator set them sample size to 30 patients. Primary endpoint (concerning both study questions): is the applied torque measurement in Newton meters (maximum up to 7.5 Nm) up to the pain tolerance limit. For the chronic injuries, a minimum of 5 Nm should be achieved. If this is not possible due to pain, an intra-articular infiltration into the upper ankle joint with 5ml Ropivacaine 2% is performed under sterile conditions. In addition, fibula translation while exercising the maximum tolerated External Torque CT (maximum up to 7.5 Nm). Secondary endpoint (1st study question): the comparison to stress fluoroscopy without anesthesia and under anesthesia. Secondary endpoint (2nd study question): the comparison of patients with and without symptoms. Secondary endpoint in patients who received intra-articular infiltration is the increase in tolerated Newton meters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
November 23, 2022
CompletedStudy Start
First participant enrolled
August 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2025
CompletedJune 19, 2025
June 1, 2025
1.7 years
November 15, 2022
June 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
External torque CT
= the applied torque measurement in Newton meters (maximum up to 7.5 Nm) up to the pain tolerance limit. In the chronic injuries, at least 5 Nm should be achieved. If this is not possible due to pain, patients with chronic injuries are infiltrated intra-articularly into the upper ankle joint with 5ml ropivacaine 2% under sterile conditions.
24 months
Study Arms (3)
Patients with acute syndesmotic injuries
The patients undergo a bilateral external torque CT.
Patients with asymptomatic chronic syndesmotic injuries
The patients undergo a bilateral external torque CT.
Patients with symptomatic chronic syndesmotic injuries
The patients undergo a bilateral external torque CT.
Interventions
The "External Torque Device" was developed, which allows bilateral stressing of the syndesmosis by external rotation. Both lower legs are stabilized by a special knee brace (the fibula remains free to float) or by the hip joints, which are end rotated on both sides, while an external rotation force of maximum 7.5Nm (or up to the respective pain threshold) can be set on both sides using torque newton meters. If no load is possible - which the examination of the syndesmosis generally does not allow - an intra-articular local anesthesia with 5ml ropivacaine 2mg/ml can be performed under sterile conditions after the patient's consent.
Eligibility Criteria
10 patients with acute syndesmotic injuries 10 patients with symptomatic chronic syndesmotic injuries 10 patients with aysmptomatic chronic syndesmotic injuries
You may qualify if:
- Written informed consent
- Patient age of ≥18 yr and ≤75 yr.
- Proven acute (\<4 weeks) syndesmosis injury (anterior and posterior) on MRI.
- Proven chronic (\>2 months) syndesmosis injury (anterior and posterior) on MRI with/without surgical stabilization performed.
- Healthy opposite side
You may not qualify if:
- A dependency between patient sponsor and/or project management
- Pregnancy (contraindication for CT): in women of childbearing age, a pregnancy test is performed in any case
- St.n. previous operation(s) of the affected lower extremity (specifically of the ankle joint).
- Severe deformities (osteoarthritis with limited function upper and lower ankle joint, metatarsophalangeal joint).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Balgrist University Hospital
Zurich, 8008, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Wirth, PD
Universitätsklinik Balgrist
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2022
First Posted
November 23, 2022
Study Start
August 31, 2023
Primary Completion
May 26, 2025
Study Completion
May 26, 2025
Last Updated
June 19, 2025
Record last verified: 2025-06